Marc Tessier-Lavigne
Marc Tessier-Lavigne | |
|---|---|
Tessier-Lavigne in 2013 | |
| 11th President of Stanford University | |
| In office September 1, 2016 – August 31, 2023 | |
| Preceded by | John L. Hennessy |
| Succeeded by | Richard Saller |
| 10th President of Rockefeller University | |
| In office March 16, 2011 – September 1, 2016 | |
| Preceded by | Paul Nurse |
| Succeeded by | Richard P. Lifton |
| Personal details | |
| Born | Marc Trevor Tessier-Lavigne December 18, 1959 |
| Children | 3 |
| Education | McGill University (BS) New College, Oxford (BA) University College London (PhD) |
| Scientific career | |
| Awards | Gruber Prize in Neuroscience 2020 |
| Fields | Neuroscience |
| Institutions | University of California, San Francisco Genentech Rockefeller University Stanford University |
| Thesis | Processing of Signals and Noise in the Outer Retina of the Salamander (1987) |
| Doctoral advisor | David Attwell |
| Other academic advisors | Thomas Jessell |
Marc Trevor Tessier-Lavigne (born December 18, 1959) is a Canadian-American neuroscientist who is co-founder, CEO and chair of AI biotech firm, Xaira Therapeutics. He is also a biology professor at Stanford University, where he previously served as its 11th president, from 2016 to 2023. Prior to Stanford, he was the 10th president of Rockefeller University in New York City, from 2011 to 2016, and a professor at the University of California, San Francisco.
He was formerly executive vice president for research and the chief scientific officer at Genentech. In 2011, he joined the boards of directors of Agios Pharmaceuticals, Regeneron Pharmaceuticals and Pfizer Inc. He later joined the board of Juno Therapeutics, in 2014, and co-founded Denali Therapeutics, joining its board, in 2015.
In 2022, the Stanford board of trustees opened an investigation into allegations that Tessier-Lavigne might have been involved in fabricating results in articles published between 2001 and 2008, while working at Genentech. He was subsequently cleared of scientific fraud and misconduct in July 2023, when the trustees' report was released, then announced that he would step down as president of Stanford, effective August 31, 2023. He is known for landmark research into the mechanisms of brain wiring during embryonic development.